Ebola Virus Disease

• EMA approval · 2026-01-16
  EMA Authorised: Ervebo (recombinant vesicular stomatitis virus (strain indiana) with a deletion of the envelope glycoprotein, replaced with the zaire ebolavirus (strain kikwit 1995) surface glycoprotein) — Merck Sharp & Dohme B.V.

  The European Medicines Agency authorised Ervebo for vaccination against Ebola virus disease, using a recombinant vesicular stomatitis virus …

• EMA approval · 2025-05-14
  EMA Authorised: Zabdeno (recombinant adenovirus type 26 (Ad26) encoding the glycoprotein (GP) of the Ebola virus Zaire (ZEBOV) Mayinga strain) — Janssen-Cilag International N.V.

  The EMA authorised Zabdeno, a recombinant Ad26 Ebola vaccine by Janssen-Cilag International N.V., for prevention of Ebola virus disease.

• EMA approval · 2025-05-14
  EMA Authorised: Mvabea (recombinant Modified Vaccinia Ankara Bavarian Nordic Virus encoding the: Ebola virus Zaire (ZEBOV) Mayinga strain glycoprotein (GP); Ebola virus Sudan Gulu strain GP; Ebola virus Taï Forest strain nucleoprotein and the Marburg virus Musoke strain GP) — Janssen-Cilag International N.V.

  EMA authorised Mvabea, a recombinant Modified Vaccinia Ankara-based vaccine developed by Janssen-Cilag International N.V., for prevention of…

• FDA approval · 2024-12-26
  FDA Approved: EBANGA — Supplemental Application (Emergent Manufacturing Operations Baltimore, LLC)

  FDA approved a supplemental application to authorize manufacturing operations for EBANGA (ansuvimab) by Emergent Manufacturing Operations Ba…

• FDA approval · 2022-05-13
  FDA Approved: INMAZEB — Supplemental Application (Regeneron Pharmaceuticals, Inc.)

  The FDA approved a supplemental application for INMAZEB, Regeneron's triple-monoclonal antibody therapy for Ebola virus disease.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• FDA approval · 2021-12-07
  FDA Approved: EBANGA — Supplemental Application (Emergent Manufacturing Operations Baltimore, LLC)

  FDA approved a supplemental application to approve Emergent Manufacturing Operations Baltimore, LLC's facility for producing EBANGA (ansuvim…

• EMA approval · 2020-05-29
  New vaccine for prevention of Ebola virus disease recommended for approval in the European Union

  The European Medicines Agency recommends approval of a new Ebola virus disease vaccine for use in the European Union to prevent Ebola virus …

• EMA approval · 2019-10-18
  First vaccine to protect against Ebola

  The EMA announced the first vaccine that protects against Ebola, marking a major advance in prevention of Ebola virus disease.